Alex Badamchi-Zadeh
InvestorSenior Associate at SV Health Investors
London
Writes $100K – $5M checks · typically $1.5M
About
Alex Badamchi-Zadeh is a biotech investor at SV Health Investors, managing positions across the SV7 Impact Medicine Fund, Biotech Crossover Opportunities Fund, and SV8 Bio Fund, and serves as an investment committee member for Cancer Research Horizons. Previously, he held business development and strategy roles at Xilio Therapeutics, a NASDAQ-listed immuno-oncology company, and worked as a life science strategy consultant at L.E.K. Consulting. His background includes immunology research at Harvard Medical School, Imperial College London, and the University of Oxford, with publications in Nature, Science Immunology, and In Vivo.
Contact· self-published, not guessed
Experience
- Stealth Immunology BiotechInvestorcurrent2026 — presentSan Francisco Bay Area
- Stealth Migraine BiotechInvestor Board Director & Founding Teamcurrent2025 — presentLondon Area, United Kingdom
- Dualitas TherapeuticsInvestor Board Observer & Founding Teamcurrent2022 — presentSan Francisco Bay Area
- Cancer Research UK (CRUK)Investment Committee Member (Cancer Research Horizons)current2022 — presentLondon Area, United Kingdom
- Nimbus TherapeuticsInvestorcurrent2022 — presentCambridge, Massachusetts, United States
- Alchemab Therapeutics LtdInvestor Board Observercurrent2020 — presentCambridge, England, United Kingdom
- SitryxInvestorcurrent2020 — presentOxford, England, United Kingdom
- SV Health InvestorsBiotech Investorcurrent2020 — presentGreater London, England, United Kingdom
- BioAge LabsInvestor2024 — 2026San Francisco Bay Area
- EyeBioInvestor Board Observer & Founding Team2021 — 2024London Area, United Kingdom
- Therini Bio, Inc.Investor2022 — 2024
- Catamaran BioInvestor2022 — 2024
- TRexBioInvestor2020 — 2023
- Xilio Therapeutics, Inc.Business Development & Strategy2018 — 2020Cambridge, Massachusetts
- L.E.K. ConsultingLife Sciences Specialist Consultant2017 — 2018Boston, Massachusetts
- Harvard Medical SchoolPostdoctoral Fellow2014 — 2017Brookline, Massachusetts
Skills & more
Investment ManagementInvestmentsImmunologyBusiness Development4Revenue Forecasting1Life Sciences6Consulting3Management Consulting1Vaccines17Infectious Diseases3Biotechnology2Financial Modeling1
+12 more
Due DiligenceCompetitive IntelligenceValuationBusiness StrategyCompetitive AnalysisCancerCorporate DevelopmentClient DevelopmentMicrosoft PowerPointMicrosoft ExcelStrategyLeadershipLanguages English
From Alex's professional profile.
Colleagues at SV Health Investors
A.J. Rossi
Partner at SV Health Investors
Aaron Sandoski
MCF Partner at SV Health Investors
Alan Foster
Managing Director at TeleSoft.AI
Amer Ramzan
Managing Partner at Promentum Equity Partners
Andrew Cappetta
Senior Associate at SV Health Investors
Brent Faduski
CFO, CCO and Partner at SV Health Investors
Charles Dunn
Principal at SV Health Investors
Christian Jung
Partner at Dementia Discovery
Network6
Charles Dunn
Principal at SV Health Investors
Christian Jung
Partner at SV Health Investors
Darren Black
Partner at SV Health Investors
Dirk Landgraf
Principal at SV Health Investors
Emily Gaudiano
Associate at SV Health Investors
Eugene Hill
Chairman at SV Health Investors
Investors connected to Alex in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Alex Badamchi-Zadeh?
- Alex Badamchi-Zadeh is a biotech investor at SV Health Investors, managing positions across the SV7 Impact Medicine Fund, Biotech Crossover Opportunities Fund, and SV8 Bio Fund, and serves as an investment committee member for Cancer Research Horizons. Previously, he held business development and strategy roles at Xilio Therapeutics, a NASDAQ-listed immuno-oncology company, and worked as a life science strategy consultant at L.E.K. Consulting. His background includes immunology research at Harvard Medical School, Imperial College London, and the University of Oxford, with publications in Nature, Science Immunology, and In Vivo.
- Where does Alex Badamchi-Zadeh work?
- Alex Badamchi-Zadeh is Senior Associate at SV Health Investors.
- What check size does Alex Badamchi-Zadeh write?
- Alex Badamchi-Zadeh typically writes checks of $100K – $5M.
- Where did Alex Badamchi-Zadeh go to school?
- Alex Badamchi-Zadeh studied at University of Oxford (BA (Hons) & MA (Oxon), Christ Church); Imperial College London (Doctor of Philosophy (PhD), Medicine (Immunology)); Harvard Business School (Economics for Managers; Business Analytics; Financial Accounting).
Same school
Also attended University of Oxford989
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index Ventures
+ 983 more
Also attended Imperial College London501
Deji SasegbonVP, Platform & Portfolio Operations at EchoVC PartnersMadison LenormandInvestor at DaphniPauline BoucherInvestor at DaphniLoubaba El AyoubiInvestor at NorthzoneGiovanni MariggiInvestor at MedicxiFrancois PrinslooInvestor at Medicxi
+ 495 more
Also attended Harvard Business School2,000
Brad GerstnerFounder & CEO of Altimeter CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesTim DraperFounder of Draper AssociatesMamoon HamidPartner at Kleiner PerkinsNeeraj AgrawalGeneral Partner at Battery VenturesHristo BorisovCo-founder & CEO of Payhawk
+ 1,994 more
Shared employers
Also worked at Cancer Research UK (CRUK)24
Drew BurdonInvestor at LSP (Life Sciences Partners)Giovanni MariggiInvestor at MedicxiDominic SchmidtGeneral Partner at Advent Life SciencesJoanna SorokaInvestment Partner at Hitachi VenturesMilenko CicmilVenture Partner at Cure VenturesMartin TaylorPrincipal at F-Prime Capital Partners
+ 18 more
